semaglutide and late period Everything you need to know about GLP-1s for weight loss Why Your Period Changes on

Cardiovascular Risk Reduction: Clinical studies have shown that semaglutide can reduce the risk of major cardiovascular events, such as heart attacks and strokes, in adults with type 2 diabetes and pre-existing cardiovascular disease

16 17 18 Newly emerging indications for GLP-1 medicationsincluding heart disease, metabolic liver disease, peripheral artery disease, Alzheimers/dementia risk, and even alcohol and substance use disorders, as highlighted in a 2025 study in JAMA 19 suggest these drugs may soon play a much broader role in medicine than just treating diabetes or obesity

Licensed providers typically recommend starting tirzepatide around your next scheduled injection daytypically seven days later

The exact mechanism that causes patients taking GLP-1 agonists to be more likely to develop eye injuries is still being researched, but some factors may include the effects of fluctuating blood sugar levels and their impact on diabetic retinopathy, the potential for hypoglycemia, and instances of allergic reactions